Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	90	112	71	106	197	128
Market Cap Growth	-1.72%	57.54%	-32.42%	-46.38%	53.54%	18.98%
Enterprise Value	78	96	62	98	183	121
PE Ratio	87.50	-120.07	-7.91	-53.99	-7.04	-7.00
PS Ratio	2.55	3.44	3.12	4.52	5047.59	133.69
PB Ratio	5.80	7.26	5.46	5.99	12.57	12.15
P/FCF Ratio	15.30	16.49	14.91	-26.19	-8.79	-6.70
P/OCF Ratio	15.27	16.49	14.80	-22.36	-8.81	-7.11
EV/Sales Ratio	2.22	2.95	2.69	4.19	4684.69	125.87
EV/EBITDA Ratio	52.82	-331.26	-9.49	-200.92	-6.90	-6.65
EV/EBIT Ratio	144.43	-80.87	-7.45	-103.11	-6.74	-6.49
EV/FCF Ratio	13.32	14.14	12.87	-24.28	-8.16	-6.31
Debt / Equity Ratio	0.32	0.35	0.50	0.38	0.46	0.43
Debt / EBITDA Ratio	3.39	-18.56	-1.01	-13.75	-0.27	-0.25
Debt / FCF Ratio	0.85	0.79	1.36	-1.66	-0.32	-0.24
Quick Ratio	1.37	1.53	2.81	4.36	5.63	6.39
Current Ratio	1.59	1.65	3.10	5.18	6.51	7.65
Asset Turnover	1.13	1.11	0.99	0.81	0.00	0.05
Interest Coverage	-	-	-10.85	-0.94	-31.56	-
Return on Equity (ROE)	5.70%	-6.20%	-70.90%	-10.30%	-322.40%	-124.50%
Return on Assets (ROA)	2.90%	-3.20%	-38.90%	-6.80%	-160.90%	-102.00%
Return on Capital (ROIC)	5.92%	-0.92%	-33.77%	0.02%	-118.88%	-123.11%
Earnings Yield	1.02%	-0.83%	-12.65%	-1.85%	-14.21%	-14.29%
FCF Yield	6.53%	6.06%	6.70%	-3.82%	-11.38%	-14.91%
Buyback Yield / Dilution	-0.93%	-1.98%	0.24%	-19.98%	-18.29%	-176.74%
Total Shareholder Return	-0.93%	-1.98%	0.24%	-19.98%	-18.29%	-176.74%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).